Role of Extracellular Vesicles in Substance Abuse and HIV-Related Neurological Pathologies

Extracellular vesicles (EVs) are membrane-bound particles released by almost all cell types, serving as critical vehicles for intercellular communication by transporting complex molecular payloads like proteins, lipids, and noncoding RNAs. This review synthesizes current knowledge on how EVs are involved in the pathophysiology of substance use disorders and HIV-related neurological complications. The authors examine how drugs of abuse—such as methamphetamine, cocaine, nicotine, opioids, and alcohol—alter EV secretion rates and molecular cargo, potentially contributing to the exacerbation of brain pathologies.

The paper highlights that drugs of abuse act as triggers that shift the biological signaling profile of EVs. For example, substances often increase the release of EVs that carry pro-inflammatory molecules, which can travel through the blood-brain barrier to recipient cells, promoting neuroinflammation and synaptic dysfunction. In the context of HIV, which frequently co-occurs with substance abuse, EVs appear to facilitate a "double hit" effect. Viral components and drug-altered EV cargoes can synergistically amplify inflammatory responses and oxidative stress within the central nervous system, worsening neurocognitive outcomes.

Beyond their role in disease progression, the authors explore the potential of using EVs as diagnostic biomarkers and therapeutic delivery vehicles. Because EVs can cross the blood-brain barrier and can be engineered to carry specific therapeutic molecules (such as siRNA or protective miRNAs), they offer a promising platform for treating neurodegenerative conditions and addiction. The review cites preliminary successes where modified EVs were used to knock down disease-linked gene expression in animal models, restoring normal cellular function and reducing drug-seeking behavior.